Find Datasets from
UMB Researchers
of 1 Next >
Results Found: 1
  • Protection from Cholera with CVD 103-HgR
    UMB Dataset

    Alternate Title(s)
    Efficacy of Single-Dose Live Oral Cholera Vaccine CVD 103-HgR
    Authors
    Wilbur H. Chen
    Myron M. Levine
    Description

    This dataset is the result of a phase 3, randomized, double-blind, placebo-controlled efficacy trial of a single dose live oral cholera vaccine. PXVX0200 was developed to rapidly confer protection to humanitarian relief workers and other travelers visiting cholera-endemic areas as well as residents in regions experiencing outbreaks. Existing licensed vaccines require 2 or 3 (children) doses weeks apart. The trial consisted of 3 groups of volunteers each of which were randomly split into receiving either the PXVX0200 vaccine or a placebo. One group was challenged with virulent V. cholera O1 El Tor Inaba strain N16961 inoculum 10 days post-vaccination. A second group was challenged 3 months post-vaccination, while individuals in the third group remained unchallenged. A total of 197 volunteers participated in the trial. This dataset includes demographics and clinical and immunology measures from the 3 study sites: University of Maryland, Baltimore School of Medicine, Cincinnati Children’s Hospital Medical Center, Ohio, and the Vaccine Testing Center, University of Vermont College of Medicine. (National clinical trial registry number: NCT01895855; Research funded by: PaxVax, Inc.)

    Subject
    Vaccines
    Geographic Coverage
    United States
    Access Rights
    Approval required
    Registration required

Filter by

Subject Domain
Geographic Coverage
Access Restrictions
Timeframe